Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline (2024)
Using AUA Guidelines
Access to AUA guidelines is provided free for individuals’ clinical use only. Anyone accessing AUA guidelines for any other purpose must obtain a license in advance. Licenses for academic, research and educational purposes can be requested through the AUA by contacting permissions@AUAnet.org.
Licenses for promotional or commercial use can be requested by contacting Keith Price at kprice@AUAnet.org.
Access FAQs on AUA clinical guideline usage and licensing.
By reading this guideline, you agree to AUA's Guidelines Terms and Conditions of Use.
Using AUA Guidelines
Access to, and limited authorized use of AUA guidelines is a member benefit. Members are granted a limited license to access and use the AUA Guidelines for their individual, non-commercial use, for clinical, academic, educational, and research purposes, in accordance with the AUA Guidelines Terms and Conditions of Use. Members who wish to use the Guidelines for any other purpose, or in any manner not authorized by this limited license grant or by the AUA Guidelines Terms and Conditions of Use must request and obtain a license/permission in advance. Licenses for business or institutional academic, research and educational related purposes (e.g., use in course packs or for employer-sponsored research) can be requested through the AUA by contacting permissions@AUAnet.org.
Licenses for promotional or commercial use can be requested by contacting Keith Price at kprice@AUAnet.org.
Access FAQs on AUA clinical guideline usage and licensing.
By reading this guideline, you agree to AUA's Guidelines Terms and Conditions of Use.
Using AUA Guidelines
Access to AUA guidelines is provided free for individual clinical use only, in accordance with the AUA Guidelines Terms and Conditions of Use. Anyone accessing AUA guidelines for any other purpose must obtain a license/permission in advance. Licenses for academic, research and educational purposes (e.g., in course packs or employer-sponsored research) can be requested through the AUA by contacting permissions@AUAnet.org.
Licenses for promotional or commercial use can be requested by contacting Keith Price at kprice@AUAnet.org.
Access FAQs on AUA clinical guideline usage and licensing.
By reading this guideline, you agree to AUA's Guidelines Terms and Conditions of Use.
Using AUA Guidelines
Access to AUA guidelines is provided free for health care providers for their individual clinical use only. Patients and the general public are provided a summary of the guidelines. Patients who wish to discuss the full guidelines should consult with their healthcare provider.
Guideline Resources
Salvage Therapy Prostate Cancer Guideline PDF
The Journal of Urology® Article Part I
The Journal of Urology® Article Part II
The Journal of Urology® Article Part III
Purpose
While definitive standard of care therapies cure most patients with clinically localized prostate cancer, the risk of recurrence, and even subsequent metastasis, is over 50% in patients with the highest disease risk features. Understanding the evaluation and appropriate use of salvage therapies for patients with biochemical recurrence is a critical area of prostate cancer care. In fact, a cure is still possible for many of these patients.
Key Takeaways
Balancing undertreatment with overtreatment, utilizing new therapeutic agents and imaging modalities, and optimizing patient selection through use of evidence-driven prognostic markers are all critical to improving oncologic outcomes and maintaining quality of life for these patients. The clinical guideline includes discussion of the following:
- Treatment decision-making at the time of suspected biochemical recurrence after primary radical prostatectomy
- Treatment delivery for non-metastatic biochemical recurrence after primary radical prostatectomy
- Evaluation and management of suspected non-metastatic recurrence after radiation therapy
- Evaluation and management of suspected non-metastatic recurrence after focal therapy
- Evaluation and management of regional recurrence
- Management for molecular imaging metastatic recurrence
Create a free account to access expanded content and resources.
AUA Clinical Practice Guidelines are developed by multidisciplinary panels of experts based on rigorous systematic review of current urologic research.
| Free Resources | |
 |
Salvage Radiation Therapy for Prostate Cancer Fact Sheet |
| Login to Continue | |
| Member Benefit | |
|
Salvage Therapy Prostate Cancer Guideline PDF |
|
The Journal of Urology® Article Part I |
|
The Journal of Urology® Article Part II |
|
The Journal of Urology® Article Part III |